NIH – Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)
09/01/2018 09:35
Objetivo: This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease.
Inscrições: até 05 de fevereiro de 2018
Mais informações no site.
